These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 8401094

  • 1. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC, Naji SA, Russell IT, Templeton AA.
    BMJ; 1993 Sep 18; 307(6906):714-7. PubMed ID: 8401094
    [Abstract] [Full Text] [Related]

  • 2. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC, Naji SA, Russell IT, Templeton AA.
    Hum Reprod; 1994 Nov 18; 9(11):2167-72. PubMed ID: 7868693
    [Abstract] [Full Text] [Related]

  • 3. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R, Naji S, Russell I, Templeton A.
    Acta Obstet Gynecol Scand; 1994 Nov 18; 73(10):812-8. PubMed ID: 7817735
    [Abstract] [Full Text] [Related]

  • 4. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA.
    Br J Obstet Gynaecol; 1997 Jul 18; 104(7):829-33. PubMed ID: 9236649
    [Abstract] [Full Text] [Related]

  • 5. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C, Olund A.
    Acta Obstet Gynecol Scand; 1993 Jan 18; 72(1):39-42. PubMed ID: 8382430
    [Abstract] [Full Text] [Related]

  • 6. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC, Templeton AA.
    Br J Obstet Gynaecol; 1991 Oct 18; 98(10):1025-30. PubMed ID: 1751434
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT, Sukcharoen N, Thong KJ.
    Hum Reprod; 1995 Jun 18; 10(6):1521-7. PubMed ID: 7593528
    [Abstract] [Full Text] [Related]

  • 8. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST, Glasier AF, Logan J, Benton L, Baird DT.
    Br J Obstet Gynaecol; 1996 Dec 18; 103(12):1222-9. PubMed ID: 8968240
    [Abstract] [Full Text] [Related]

  • 9. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC, Kelly T, Howel D, Deverill M, Hewison J, Lie ML, Stamp E, Armstrong N, May CR.
    Health Technol Assess; 2009 Nov 18; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [Abstract] [Full Text] [Related]

  • 10. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE, Thong KJ, Rodger MW, Baird DT.
    Br J Obstet Gynaecol; 1992 Jul 18; 99(7):601-6. PubMed ID: 1525104
    [Abstract] [Full Text] [Related]

  • 11. Women's evaluation of three early abortion methods.
    Holmgren K.
    Acta Obstet Gynecol Scand; 1992 Dec 18; 71(8):616-23. PubMed ID: 1336921
    [Abstract] [Full Text] [Related]

  • 12. A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
    Tang GW.
    Contraception; 1991 Nov 18; 44(5):523-32. PubMed ID: 1797467
    [Abstract] [Full Text] [Related]

  • 13. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, Baulieu EE.
    Acta Obstet Gynecol Scand; 1992 May 18; 71(4):278-83. PubMed ID: 1322621
    [Abstract] [Full Text] [Related]

  • 14. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Thong KJ, Lynch P, Baird DT.
    Contraception; 1996 Aug 18; 54(2):97-100. PubMed ID: 8842586
    [Abstract] [Full Text] [Related]

  • 15. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT, Baird DT.
    Br J Obstet Gynaecol; 1988 Mar 18; 95(3):271-6. PubMed ID: 3370199
    [Abstract] [Full Text] [Related]

  • 16. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H, Hinshaw K, Templeton A.
    Hum Reprod; 1993 Oct 18; 8(10):1744-6. PubMed ID: 8300840
    [Abstract] [Full Text] [Related]

  • 17. Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
    Tang GW, Lau OW, Yip P.
    Contraception; 1993 Sep 18; 48(3):267-76. PubMed ID: 8222656
    [Abstract] [Full Text] [Related]

  • 18. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
    Urquhart DR, Templeton AA.
    Br J Obstet Gynaecol; 1991 Apr 18; 98(4):396-9. PubMed ID: 2031899
    [Abstract] [Full Text] [Related]

  • 19. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ, Baird DT.
    Br J Obstet Gynaecol; 1993 Aug 18; 100(8):758-61. PubMed ID: 8399016
    [Abstract] [Full Text] [Related]

  • 20. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW, Brown AH, Baird DT.
    Contraception; 1998 Aug 18; 58(2):99-103. PubMed ID: 9773264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.